Discuss emergency management of massive pulmonary embolism

Reading File

Finding Sources

Searching PubMed

"massive pulmonary embolism" AND "emergency management"

Reading File

Searching PubMed

"pulmonary embolism" AND "thrombolysis" AND "management"

Finding Sources

Reading File

Loading Image

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

Reading File

Finding Sources

I now have comprehensive, detailed content from multiple authoritative textbooks. I also have the key management flowchart. Let me now compile the complete answer.

Emergency Management of Massive Pulmonary Embolism

Autopsy Image: Massive PE

Autopsy photograph showing massive pulmonary embolism completely occluding the right ventricular outflow system

Autopsy photograph showing a massive pulmonary embolism (dark thrombus) completely occluding the right ventricular outflow system. (Rosen's Emergency Medicine, 10e)

1. Definition and Classification

Massive (high-risk) PE is defined by hemodynamic instability, specifically:

Systolic BP < 90 mmHg sustained for ≥15 minutes not attributable to dysrhythmia or other cause
A drop in baseline SBP of >40 mmHg
Requirement for vasopressors
Profound bradycardia (<40 bpm)

Category	Criteria	Mortality
Low-risk	Normotensive, no RV dysfunction	~1.1%
Intermediate-risk	Normotensive + RV dysfunction and/or elevated troponin/BNP	Elevated
High-risk (Massive)	Hemodynamically unstable	25-50%

2. Pathophysiology of Hemodynamic Collapse

When a large thrombus obstructs >50% of the pulmonary vascular bed, pulmonary artery pressure rises acutely. The right ventricle, which is a thin-walled, low-pressure chamber, is unable to sustain this sudden afterload increase. This produces:

Acute RV dilation - the RV distends toward the interventricular septum ("D-sign")
Septal bowing - this reduces LV filling volume and cardiac output
Myocardial ischemia - RV wall tension compresses coronary perfusion; septal tension on the AV node may produce agonal rhythms
PEA arrest - the most common cardiac arrest rhythm in PE (>20 depolarizations/min without palpable pulses)

Approximately 25% of sudden cardiac deaths are attributed to PE. Prior to arrest, the classic finding is a shock index >1 (HR > systolic BP), combined with hypoxia, overt respiratory distress, syncope, and severe anxiety.

3. Immediate Resuscitation Priorities

A. Airway and Oxygenation

Supplemental oxygen targeting SpO₂ >90% to prevent hypoxic pulmonary vasoconstriction (which worsens acute pulmonary hypertension)
Avoid intubation whenever possible - positive-pressure ventilation increases intrathoracic pressure, reduces preload, and can precipitate complete hemodynamic collapse in severe PE
When intubation is unavoidable, optimize hemodynamics with vasopressors before induction

B. Hemodynamic Resuscitation

Cautious fluid resuscitation: small boluses (250-500 mL) may improve cardiac output, but aggressive fluid loading worsens RV distension and further compresses the LV - use with restraint
Vasopressors: norepinephrine is the first-line vasopressor for hemodynamic support
Dobutamine: useful adjunct for RV support, but may worsen hypotension unless co-administered with norepinephrine

C. Anticoagulation

Initiate IV unfractionated heparin (UFH) immediately in all suspected massive PE - UFH is preferred when thrombolysis or surgical intervention is being considered (short half-life allows rapid reversal)
Do not delay anticoagulation while awaiting imaging in hemodynamically unstable patients with high clinical suspicion

4. Definitive Treatment: Reperfusion

Management Flowchart

Flowchart showing the treatment approach to patients diagnosed with acute pulmonary embolism in the emergency department

PE Management Algorithm - Rosen's Emergency Medicine, 10e. High-risk PE patients: if no cardiac arrest and no contraindications → systemic thrombolysis; if relative contraindications → CDT or low-dose thrombolysis; if absolute contraindications → surgical/catheter thrombectomy; if persistent hemodynamic instability despite above → ECMO.

4a. Systemic Thrombolysis (First-Line for Massive PE)

Systemic thrombolysis is the treatment of choice for massive PE without contraindications. Thrombolytics activate plasminogen to plasmin, which degrades fibrin within the thrombus.

Dosing Regimens:

Agent	Dose	Route
Alteplase (rtPA) - standard	100 mg IV over 2 hours	IV infusion
Alteplase - low dose	25-50 mg IV over 2 hours	IV infusion
Reteplase	10 units IV bolus, repeated at 30 min	IV bolus ×2
Tenecteplase	Single weight-based bolus over 5-10 seconds	IV bolus

Alteplase has a half-life of ~5 minutes (cleared hepatically); during infusion, plasma concentrations reach 300-3000 ng/mL, which degrades systemic fibrinogen. Reteplase and tenecteplase offer longer half-lives and convenient bolus dosing, with similar efficacy and toxicity to alteplase.

Efficacy: Thrombolysis reduces mortality and hemodynamic collapse but carries a 2-4% major hemorrhage rate and up to 1% intracranial hemorrhage rate.

Absolute Contraindications to Thrombolysis:

GI bleeding within the previous 30 days
Active hemorrhage (intraperitoneal, retroperitoneal, pulmonary, uterine, bladder, nasal)
Recent intracranial surgery or head trauma
Intracranial neoplasm or brain metastasis
History of hemorrhagic stroke
Aortic dissection
Liver failure (INR >1.7)
Surgery requiring opening of the chest, peritoneum, skull, or spinal canal within the previous 14 days
Subacute bacterial endocarditis under treatment
Pregnancy
Large pericardial effusion

Relative Contraindications:

Age >75 years; dementia
Surgery 30-60 days prior; any prior stroke
Symptoms suggesting TIA in past 30 days
Any prior GI bleeding; concurrent thienopyridine use (e.g., clopidogrel)
INR >1.7 from warfarin; metastatic cancer
Recent fracture, head strike, hematuria, dental extraction, or orthopedic surgery

Note: In cardiac arrest from PE, thrombolytics can and should be given despite standard CPR activity - this is not a contraindication in the arrest setting.

4b. Catheter-Directed Thrombolysis (CDT)

CDT delivers a lower dose of thrombolytic directly into the thrombus via a catheter positioned in the pulmonary artery, reducing systemic drug exposure and potentially lowering hemorrhagic risk. It is preferred when patients have:

Relative contraindications to systemic thrombolysis
Intermediate-high risk PE requiring advanced intervention
Failed systemic thrombolysis

Ultrasound-assisted CDT (e.g., the EKOS system) uses high-frequency, low-power ultrasound to facilitate drug penetration. The SEATTLE II study and subsequent meta-analyses support its safety and efficacy in intermediate and high-risk PE, though head-to-head comparisons with systemic thrombolysis in truly massive PE are limited.

4c. Surgical Embolectomy

Surgical pulmonary embolectomy is performed via median sternotomy on cardiopulmonary bypass. It is indicated for:

Massive PE with absolute contraindications to thrombolysis
Failed thrombolysis with persistent hemodynamic compromise
Presence of intracardiac thrombus or patent foramen ovale (PFO) with paradoxical embolism risk

Perioperative mortality is highest in patients who require CPR before surgery and lowest in patients who are stabilized beforehand. Importantly:

Placing an IVC filter before surgery in stable patients reduces operative mortality
Prior thrombolytic administration does not absolutely preclude surgery - patients can undergo sternotomy after thrombolytics and survive without fatal hemorrhage, but this decision rests with the cardiothoracic surgeon

Emergency physicians should involve an experienced cardiothoracic surgeon as early as possible in the care of potential embolectomy patients.

4d. Percutaneous Mechanical Thrombectomy (Aspiration/Fragmentation)

Catheter-based mechanical devices allow aspiration or fragmentation of clot without thrombolytics. Options include:

Aspiration thrombectomy (e.g., FlowTriever, Indigo system)
Ultrasound-assisted CDT

A 2025 systematic review and meta-analysis (Choksi et al., PMID 39365670) compared aspiration thrombectomy vs. ultrasound-accelerated thrombolysis, supporting both techniques in appropriate patients.

4e. Extracorporeal Membrane Oxygenation (ECMO)

ECMO - particularly veno-arterial ECMO (VA-ECMO) - serves as:

A bridge to definitive therapy (CDT, surgical embolectomy, or catheter thrombectomy)
A rescue strategy for refractory hemodynamic instability despite all other interventions

ECMO unloads the right ventricle and restores cardiac output while the thrombus is treated. Survival of PE patients requiring ECMO is approximately 70%. ECMO requires institutional infrastructure and specialized expertise, limiting its availability to tertiary centers. Extracorporeal CPR (ECPR) also enables resuscitation of cardiac arrest from PE at centers where it is available.

5. Pulmonary Embolism Response Teams (PERT)

PERTs are multidisciplinary rapid-response teams including emergency physicians, cardiologists, pulmonologists, vascular/cardiothoracic surgery, and interventional radiology. Key points:

~60% of PERT activations originate in the ED
PERTs facilitate access to advanced therapies (CDT, surgery, ECMO) and reduce disposition times
Current guidelines recommend PERT activation for all intermediate-high and high-risk PE patients
Activate PERT early - do not wait for hemodynamic deterioration to call for help

6. IVC Filters

IVC filter placement is indicated in a narrow subset:

Confirmed PE with an absolute contraindication to anticoagulation (e.g., recent cerebral hemorrhage, large cerebral infarction, brain metastases)
Central PE in a patient unlikely to survive embolization of a proximal (iliofemoral) mobile DVT

Retrievable filters are preferred. Contact interventional radiology/cardiology urgently for placement in these scenarios.

7. Cardiac Arrest Management in PE

PEA is the most common arrest rhythm
If PE is suspected as the cause of PEA, give empirical thrombolysis (alteplase 50 mg IV bolus)
Continue CPR for at least 60-90 minutes after thrombolytic administration before considering cessation - thrombolytics take time to work
If available, ECPR/VA-ECMO should be deployed during or after resuscitation

8. Summary of Priorities

Priority	Action
Airway	O₂ to SpO₂ >90%; avoid intubation if possible
Hemodynamics	Cautious fluids (250-500 mL boluses); norepinephrine; dobutamine as adjunct
Anticoagulation	IV UFH immediately
Reperfusion	Systemic alteplase 100 mg/2h if no contraindications
If contraindicated	CDT, surgical embolectomy, or mechanical thrombectomy
Refractory shock	ECMO as bridge to definitive therapy
Team activation	PERT immediately for high-risk PE

Recent Evidence Updates (2023-2026)

ACR Appropriateness Criteria 2025 (PMID 41193046) and 2025 ESVM Guidelines (PMID 40587333) both support catheter-directed interventions as valid alternatives to systemic thrombolysis in high-risk PE, particularly when bleeding risk is elevated.
A 2025 meta-analysis (Choksi et al., PMID 39365670) found that aspiration thrombectomy and ultrasound-accelerated thrombolysis had comparable safety and efficacy - supporting the role of catheter-based strategies alongside traditional thrombolysis.
The trend in 2024-2026 guidelines is toward earlier PERT activation and more individualized decisions using catheter-based therapy, rather than defaulting to systemic thrombolysis for all massive PE patients.

Sources: Rosen's Emergency Medicine: Concepts and Clinical Practice, 10e; Tintinalli's Emergency Medicine; Goodman & Gilman's Pharmacological Basis of Therapeutics; Murray & Nadel's Textbook of Respiratory Medicine; Miller's Anesthesia, 10e; ACR/ESVM Guidelines 2025.

1.Explain interpretation of general urinalysis in renal pathology.

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

Reading File

Loading Image

Reading File

I now have comprehensive content from all major nephrology textbooks. Let me compile the full, detailed answer.

Interpretation of General Urinalysis in Renal Pathology

Urinalysis is often called the "liquid biopsy of the kidney." It provides diagnostic and prognostic information that complements serum markers (creatinine, eGFR), and in many conditions it is the earliest indicator of renal disease - appearing before any decline in GFR is detected. A complete urinalysis has three components: macroscopic assessment, dipstick (chemical) analysis, and microscopic examination of urine sediment.

PART 1 — MACROSCOPIC ASSESSMENT

1a. Urine Color

Normal urine is pale to deep yellow, colored by urochrome. Color changes carry important diagnostic clues:

Color	Cause	Pathologic Significance
Pink/Red	Gross hematuria, hemoglobinuria, myoglobinuria	Glomerulonephritis, rhabdomyolysis, tumor
Red urine + red sediment	Intact RBCs	Hematuria (glomerular or urological)
Red urine + clear sediment	Free hemoglobin or myoglobin	Intravascular hemolysis; rhabdomyolysis
Brown/cola-colored	Heme pigments, hemosiderin	Hemolysis; myoglobinuria; severe glomerulonephritis
Yellow-brown	Bilirubin	Jaundice; hepatorenal syndrome
White/milky	Pyuria, chyluria, lipiduria	UTI; nephrotic syndrome (lipiduria)
Colorless	Dilute urine (low osmolality)	Diabetes insipidus; overhydration

Key clinical point: Red urine in the absence of RBCs on microscopy indicates hemoglobinuria (serum is pink) or myoglobinuria (serum is clear). Myoglobin casts indicate AKI from rhabdomyolysis.

1b. Urine Odor

Ammonia: bacterial infection (urease-producing organisms)
Fruity/sweet: ketonuria (DKA, starvation)
Mousy: phenylketonuria
Maple syrup: maple syrup urine disease
Fishy: hypermethioninemia; trimethylaminuria

1c. Turbidity/Clarity

Normal urine is clear. Cloudy urine is most commonly due to leukocytes and bacteria (UTI/pyelonephritis). It may also result from phosphate crystals (alkaline urine), urate crystals (acidic urine), or lipiduria in nephrotic syndrome.

PART 2 — DIPSTICK (CHEMICAL) ANALYSIS

2a. Specific Gravity (SG) and Osmolality

Normal SG: 1.003-1.030
SG of 1.001-1.003 = isosthenuria (inability to concentrate) - seen in chronic kidney disease (CKD), diabetes insipidus
SG 1.008-1.010 = isosthenuric range (equal to plasma osmolality ~280 mOsmol/kg)
High SG (>1.020): dehydration, prerenal azotemia, SIADH, glucosuria (glucose adds to weight but not ionic strength, causing discrepancy between dipstick and refractometry)
Fixed SG of 1.010: loss of tubular concentrating and diluting ability; hallmark of end-stage renal disease

Osmolality is the gold standard for concentration. Urine SG rises ~0.001 per 35-40 mOsmol/kg increase in osmolality. SG ≤1.003 by refractometry always indicates maximally dilute urine (≤100 mOsmol/kg).

2b. Urine pH

Normal range: 4.5 to 7.8
Alkaline urine (>7.0): infection with urease-producing organisms (Proteus mirabilis, Ureaplasma), renal tubular acidosis type I (distal), metabolic alkalosis
Acidic urine (<5.5): metabolic acidosis, uric acid crystals/stones
Persistently alkaline despite systemic acidosis: distal RTA (inability to acidify urine below pH 5.5)

2c. Protein

Normal: <150 mg/day of total protein; <30 mg/day of albumin
Dipstick detects: primarily albumin; threshold ~200-300 mg/L (trace = 15-30 mg/dL)
Dipstick can be falsely positive with: concentrated urine, alkaline pH, hematuria, antiseptic contamination
Dipstick can be falsely negative for: low-molecular-weight (LMW) proteins (light chains in myeloma, β2-microglobulin in tubular disease)

Types and clinical interpretation:

Type	Mechanism	Examples	Level
Glomerular	Loss of size/charge selectivity	GN, diabetic nephropathy, FSGS	Often >1 g/day; albumin-predominant
Tubular	Impaired proximal reabsorption of LMW proteins	Fanconi syndrome, Dent disease, cisplatin toxicity	Usually <2 g/day; non-albumin proteins
Overflow	Excess production exceeds resorption capacity	Myeloma (Bence-Jones), rhabdomyolysis, hemolysis	Variable
Postrenal	Inflammation in urinary tract	UTI, stones	Small amounts; nonalbumin IgG/IgA

KDIGO Albuminuria Categories (Brenner & Rector's, 2022):

Category	AER (mg/24h)	ACR (mg/g)	Significance
A1 (Normal-mild)	<30	<30	Normal or early marker
A2 (Moderately increased)	30-300	30-300	Historically "microalbuminuria"; earliest CKD/DM marker
A3 (Severely increased)	>300	>300	Overt nephropathy; nephrotic range if >3.5 g/day

Nephrotic-range proteinuria: >3.5 g/day in adults; >40 mg/m²/h in children. Associated with: edema, hypoalbuminemia, hyperlipidemia, lipiduria.

Albuminuria is now a KDIGO criterion for CKD staging and is a stronger predictor of progression to ESKD and cardiovascular mortality than eGFR alone.

2d. Glucose (Glucosuria)

Normally absent (glucose is fully reabsorbed by SGLT2 in the proximal tubule)
With normal blood glucose (euglycemic glucosuria): proximal tubule defect - Fanconi syndrome, SGLT2 inhibitor therapy, hereditary renal glucosuria
With hyperglycemia: exceeds tubular threshold (~180 mg/dL) - diabetes mellitus
Clinical pearl: glucosuria in the absence of hyperglycemia is a key finding of Fanconi syndrome (tubular dysfunction)

2e. Blood / Hemoglobin

The dipstick detects both intact RBCs and free hemoglobin/myoglobin by peroxidase activity.

Positive dipstick + RBCs on microscopy = true hematuria
Positive dipstick + no RBCs = hemoglobinuria or myoglobinuria
False positives: myoglobin, oxidizing agents, bacterial peroxidase, povidone-iodine
False negatives: high vitamin C concentration

2f. Leukocyte Esterase and Nitrites

Leukocyte esterase (+): pyuria (>5 WBC/hpf); indicates infection, AIN, or glomerulonephritis
Nitrites (+): nitrate-reducing bacteria (Gram-negatives); specific for bacterial UTI but not sensitive
Sterile pyuria (positive leukocyte esterase, negative nitrites, negative culture): tuberculosis, AIN, interstitial nephritis, papillary necrosis, contamination

2g. Ketones

Detected when ketoacidosis is present (DKA, starvation, alcoholic ketoacidosis). Dipstick primarily detects acetoacetate, not beta-hydroxybutyrate (may underestimate severity).

2h. Bilirubin and Urobilinogen

Bilirubin (+): conjugated hyperbilirubinemia; hepatocellular disease or obstructive jaundice
Urobilinogen (elevated): hepatocellular disease, hemolytic anemia

PART 3 — URINE MICROSCOPY (SEDIMENT EXAMINATION)

Urine microscopy is often called the "most important and most underutilized" diagnostic tool in nephrology. Casts are pathognomonic of renal origin; they form in the tubular lumen when Tamm-Horsfall glycoprotein (uromodulin, secreted by the thick ascending limb of Henle) aggregates and traps cells, debris, or protein within the tubule.

Key principle: Casts are the only formed elements of urine that originate exclusively in the kidney.

3a. Red Blood Cells (Erythrocytes)

Normal: 0-2 RBCs/hpf; >3 RBCs/hpf is abnormal (microscopic hematuria).

Isomorphic RBCs (uniform biconcave discs, similar to circulating RBCs):

Indicate non-glomerular bleeding: urological source (tumor, stones, cystitis, trauma, prostatitis)
RBCs may appear crenated in hypertonic urine or as "ghost cells" in dilute urine

Dysmorphic RBCs (irregular contours, blebs, fragmentation from osmotic and pH changes as cells traverse the tubule):

Isomorphic and dysmorphic erythrocytes in urine sediment

Urine erythrocytes: (A) Isomorphic RBCs with some crenation. (B) Dysmorphic RBCs. (C) Acanthocytes (G1 cells) with membrane blebs - specific for glomerular hematuria. (D) WBCs for comparison. (Brenner & Rector's The Kidney)

Indicate glomerular origin (passage through damaged GBM causes deformation)
Acanthocytes (G1 cells): doughnut shape with membrane blebs; most specific for glomerular hematuria
Generally >10-80% dysmorphic RBCs (threshold varies by institution) = glomerular source
RBC casts + dysmorphic RBCs = pathognomonic of glomerulonephritis

Clinical significance of hematuria:

Persistent microscopic hematuria (≥3 RBCs/hpf on ≥2 samples) warrants investigation
Associated with 19.5× increased hazard for ESKD in long-term follow-up studies
Warfarin-induced nephropathy: over-anticoagulation → glomerular RBC cast formation → tubular obstruction → AKI

3b. White Blood Cells (Leukocytes)

Normal: 0-5 WBCs/hpf

Finding	Interpretation
Pyuria with bacteria	UTI / pyelonephritis
Pyuria without bacteria (sterile pyuria)	AIN, TB, NSAID nephropathy, papillary necrosis
Leukocyte casts	Pyelonephritis or acute interstitial nephritis
Eosinophiluria	Classically described in drug-induced AIN (low sensitivity/specificity)

3c. Renal Tubular Epithelial Cells (RTECs)

RTECs are larger than WBCs, with eccentric nuclei. They are the hallmark cells of tubular injury.

RTECs + granular casts + epithelial casts = acute tubular necrosis (ATN) - the hallmark triad
RTECs are rarely seen in prerenal AKI (where hyaline casts predominate)
Scoring systems based on RTEC/granular cast counts predict AKI progression, dialysis need, and death
Decoy cells: RTECs infected with BK polyomavirus, showing characteristic ground-glass nuclei (see figure below) - important in renal transplant recipients

Decoy cells from BK polyomavirus infection

Decoy cells in urine: (A) Ground-glass nucleus (phenotype 1). (B) CMV-like intranuclear inclusion (phenotype 2). (C) Binucleated cell. (D) Clumped chromatin (phenotype 4). Seen in BK virus nephropathy in transplant recipients. (Comprehensive Clinical Nephrology, 7e)

PART 4 — URINARY CASTS

Casts form when Tamm-Horsfall protein precipitates under conditions of:

Low tubular flow (stasis)
Acidic pH
High ionic concentration
Increased protein load

Cast width reflects the tubular diameter: broad casts form in dilated tubules or collecting ducts and indicate severe, widespread tubular damage - a poor prognostic sign.

Cast Types and Clinical Significance:

Cast Type	Appearance	Clinical Meaning
Hyaline	Pale, translucent; nearly invisible on bright-field	Normal in small numbers; increases with dehydration, diuretics, fever, exercise, prerenal azotemia
Granular	Coarse or fine granules from degenerated cells	Nonspecific tubular injury; ATN (with RTECs); CKD
Waxy	Dense, refractile, brittle-looking; high RI	Advanced/chronic renal disease; tubular stasis
Fatty	Contains fat droplets; Maltese cross under polarized light	Nephrotic syndrome (massive proteinuria + lipiduria)
RBC (erythrocyte)	Contains RBCs; red-orange color	Always pathologic: glomerulonephritis; vasculitis
WBC (leukocyte)	Contains neutrophils	Pyelonephritis; acute interstitial nephritis
Epithelial	Contains RTECs	ATN; severe tubular injury
Hemoglobin/pigment	Yellow-red to brown; pigmented	Severe glomerulonephritis; intravascular hemolysis; rhabdomyolysis
Myoglobin	Red-brown	AKI due to rhabdomyolysis
Broad/Waxy	2-6× normal width; waxy	Severe CKD; dialysis-grade disease; poor prognosis

Granular cast under microscopy - hallmark of ATN

Granular cast (×200) - a hallmark of acute tubular necrosis in combination with RTECs and epithelial casts. (Henry's Clinical Diagnosis and Management, 23e)

Red cell casts are ALWAYS pathologic and indicate significant glomerular pathology. (Brenner & Rector's The Kidney)

PART 5 — CRYSTALS

Crystals are identified by their shape, color, and solubility characteristics.

Crystal	Appearance	Clinical Significance
Calcium oxalate (monohydrate)	Envelope/dumbbell-shaped	Calcium oxalate nephrolithiasis; ethylene glycol poisoning (needle-shaped monohydrate)
Uric acid	Yellow-brown rhomboids/rosettes; soluble in alkali	Urate nephropathy; gout; tumor lysis syndrome
Triple phosphate (struvite)	Coffin-lid shaped	UTI with urease-producing organisms; staghorn calculi
Cystine	Hexagonal flat plates	Cystinuria (pathognomonic)
Calcium phosphate	Prism-shaped	Nephrocalcinosis; distal RTA
Bilirubin	Yellow needle clusters	Bilirubinuria

Massive uric acid crystalluria in the setting of tumor lysis syndrome causes acute urate nephropathy with AKI and pink (uric acid) discoloration of urine.

PART 6 — URINE SEDIMENT PROFILES IN SPECIFIC RENAL DISEASES

The following table synthesizes findings into diagnostic profiles (Comprehensive Clinical Nephrology, 7e):

Disease	Hallmark Finding	Associated Features	Proteinuria
Prerenal AKI	Hyaline ± hyaline-granular casts	High SG, low pH	Absent or minimal
Acute Tubular Necrosis (ATN)	RTECs + epithelial casts + granular casts	Pigmented casts (if hemolysis/myolysis)	Absent to +
Acute Interstitial Nephritis (AIN)	Leukocytes + isomorphic RBCs	RTECs, leukocyte casts, RBC casts	Absent to +
Active Proliferative GN	Dysmorphic RBCs (30-100+/hpf) + RBC/hemoglobin casts	Leukocytes, RTECs, waxy casts	+ to ++++
Nephrotic Syndrome	Fatty casts + fat oval bodies + "Maltese cross"	RTECs, hyaline/granular casts; few RBCs	++++ (>3.5 g/day)
Urinary Tract Infection	Bacteria + leukocytes	Transitional cells, struvite crystals (if urease)	Absent
Pyelonephritis	Leukocyte casts + RTECs	Bacteria, leukocytes	Absent to trace
Urological disease	Isomorphic RBCs	Transitional/malignant cells; crystals	Absent
BK virus nephropathy	Decoy cells	Decoy cell casts, macrophages	Absent
Rhabdomyolysis	Myoglobin casts (red-brown)	No RBCs on microscopy; dipstick positive	Trace
Advanced CKD	Broad waxy casts ("renal failure casts")	All cast types; low SG, isosthenuria	Variable

"Telescoped Sediment"

This term describes the simultaneous presence of both nephritic (RBC casts, dysmorphic RBCs) and nephrotic (fatty casts, oval fat bodies) elements in the same specimen. It is classically seen in:

Lupus nephritis (Class IV/V)
IgA nephropathy with nephrotic features
Membranoproliferative GN
Rapidly progressive GN

PART 7 — SUMMARY: KEY CLINICAL INTERPRETIVE PRINCIPLES

RBC casts - always abnormal; point to glomerular disease (GN, vasculitis, lupus)
Dysmorphic RBCs - glomerular bleeding; when >10-80% of RBCs are dysmorphic, suspect GN
RTECs + granular casts - ATN; score correlates with dialysis need and mortality
Leukocyte casts - AIN or pyelonephritis; sterile pyuria suggests AIN or TB
Fatty casts + lipiduria - nephrotic syndrome; look for Maltese cross under polarized light
Broad/waxy casts - advanced CKD; dialysis-level nephron loss; poor prognosis
High proteinuria (>3.5 g/day) + normal sediment - minimal change disease or membranous nephropathy
Isosthenuria (SG fixed at 1.010) - loss of tubular concentrating ability; ESKD or severe CKD
Glucosuria with normo-glycemia - proximal tubular dysfunction (Fanconi syndrome)
Cystine crystals - pathognomonic for cystinuria
Uric acid crystals in quantity + AKI - tumor lysis syndrome / acute urate nephropathy
Decoy cells in transplant recipient - BK polyomavirus nephropathy; screen with viral PCR

Sources: Brenner and Rector's The Kidney, 11e; Comprehensive Clinical Nephrology, 7e; Henry's Clinical Diagnosis and Management by Laboratory Methods, 23e; Tietz Textbook of Laboratory Medicine, 7e; Goldman-Cecil Medicine

This is a shared conversation. Sign in to Orris to start your own chat.